tetradecanoylphorbol acetate has been researched along with exenatide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, JS; Han, MS; Ku, SK; Na, DH; Park, EJ | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and exenatide
Article | Year |
---|---|
Exendin-4 inhibits endothelial protein C receptor shedding in vitro and in vivo.
Topics: Animals; Blood Coagulation Factors; Cecum; Cyclic AMP; Endothelial Cells; Exenatide; Human Umbilical Vein Endothelial Cells; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Peptides; Phosphorylation; Primary Cell Culture; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Venoms | 2014 |